149 related articles for article (PubMed ID: 31395407)
1. Fatalities related to new psychoactive substances in Singapore-A case series.
Chan S; Wu J; Lee B
Forensic Sci Int; 2019 Nov; 304():109892. PubMed ID: 31395407
[TBL] [Abstract][Full Text] [Related]
2. Fatal intoxication of a regular drug user following N-ethyl-hexedrone and ADB-FUBINACA consumption.
Kovács K; Kereszty É; Berkecz R; Tiszlavicz L; Sija É; Körmöczi T; Jenei N; Révész-Schmehl H; Institóris L
J Forensic Leg Med; 2019 Jul; 65():92-100. PubMed ID: 31128567
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of use and acute toxicity associated with the use of NBOMe drugs.
Wood DM; Sedefov R; Cunningham A; Dargan PI
Clin Toxicol (Phila); 2015 Feb; 53(2):85-92. PubMed ID: 25658166
[TBL] [Abstract][Full Text] [Related]
4. Three fatalities associated with the synthetic cannabinoids 5F-ADB, 5F-PB-22, and AB-CHMINACA.
Angerer V; Jacobi S; Franz F; Auwärter V; Pietsch J
Forensic Sci Int; 2017 Dec; 281():e9-e15. PubMed ID: 29133010
[TBL] [Abstract][Full Text] [Related]
5. Evolution of the NBOMes: 25C- and 25B- Sold as 25I-NBOMe.
Laskowski LK; Elbakoush F; Calvo J; Exantus-Bernard G; Fong J; Poklis JL; Poklis A; Nelson LS
J Med Toxicol; 2015 Jun; 11(2):237-41. PubMed ID: 25387562
[TBL] [Abstract][Full Text] [Related]
6. Supraventricular tachycardia and acute confusion following ingestion of e-cigarette fluid containing AB-FUBINACA and ADB-FUBINACA: a case report with quantitative analysis of serum drug concentrations.
Lam RPK; Tang MHY; Leung SC; Chong YK; Tsui MSH; Mak TWL
Clin Toxicol (Phila); 2017 Aug; 55(7):662-667. PubMed ID: 28393558
[TBL] [Abstract][Full Text] [Related]
7. Fatal intoxication with new synthetic cannabinoids AMB-FUBINACA and EMB-FUBINACA.
Adamowicz P; Meissner E; Maślanka M
Clin Toxicol (Phila); 2019 Nov; 57(11):1103-1108. PubMed ID: 30806094
[No Abstract] [Full Text] [Related]
8. 25I-NBOMe related death in Australia: a case report.
Kueppers VB; Cooke CT
Forensic Sci Int; 2015 Apr; 249():e15-8. PubMed ID: 25747271
[TBL] [Abstract][Full Text] [Related]
9. Fatal Intoxications with 25B-NBOMe and 25I-NBOMe in Indiana During 2014.
Shanks KG; Sozio T; Behonick GS
J Anal Toxicol; 2015 Oct; 39(8):602-6. PubMed ID: 26378133
[TBL] [Abstract][Full Text] [Related]
10. In vitro characterization of potential CYP- and UGT-derived metabolites of the psychoactive drug 25B-NBOMe using LC-high resolution MS.
Boumrah Y; Humbert L; Phanithavong M; Khimeche K; Dahmani A; Allorge D
Drug Test Anal; 2016 Feb; 8(2):248-56. PubMed ID: 26382567
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel psychoactive substances 25B-NBOMe and 4-CMC in biological material using HPLC-Q-TOF-MS and their quantification in blood using UPLC-MS/MS in case of severe intoxications.
Wiergowski M; Aszyk J; Kaliszan M; Wilczewska K; Anand JS; Kot-Wasik A; Jankowski Z
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jan; 1041-1042():1-10. PubMed ID: 27992785
[TBL] [Abstract][Full Text] [Related]
12. A case of 5F-ADB / FUB-AMB abuse: Drug-induced or drug-related death?
Ivanov ID; Stoykova S; Ivanova E; Vlahova A; Burdzhiev N; Pantcheva I; Atanasov VN
Forensic Sci Int; 2019 Apr; 297():372-377. PubMed ID: 30850157
[TBL] [Abstract][Full Text] [Related]
13. Mono-/polyintoxication with 5F-ADB: A case series.
Kraemer M; Fels H; Dame T; Musshoff F; Halter S; Mogler L; Hess C; Madea B; Maas A
Forensic Sci Int; 2019 Aug; 301():e29-e37. PubMed ID: 31138461
[TBL] [Abstract][Full Text] [Related]
14. Case series: toxicity from 25B-NBOMe--a cluster of N-bomb cases.
Gee P; Schep LJ; Jensen BP; Moore G; Barrington S
Clin Toxicol (Phila); 2016; 54(2):141-6. PubMed ID: 26621342
[TBL] [Abstract][Full Text] [Related]
15. Intoxication from the novel synthetic cannabinoids AB-PINACA and ADB-PINACA: A case series and review of the literature.
Armenian P; Darracq M; Gevorkyan J; Clark S; Kaye B; Brandehoff NP
Neuropharmacology; 2018 May; 134(Pt A):82-91. PubMed ID: 29037744
[TBL] [Abstract][Full Text] [Related]
16. Novel psychoactive substances.
Krabseth HM; Tuv SS; Strand MC; Karinen RA; Wiik E; Vevelstad MS; Westin AA; Øiestad EL; Vindenes V
Tidsskr Nor Laegeforen; 2016 May; 136(8):714-7. PubMed ID: 27143461
[TBL] [Abstract][Full Text] [Related]
17. Two cases of severe intoxication associated with analytically confirmed use of the novel psychoactive substances 25B-NBOMe and 25C-NBOMe.
Tang MH; Ching CK; Tsui MS; Chu FK; Mak TW
Clin Toxicol (Phila); 2014 Jun; 52(5):561-5. PubMed ID: 24779864
[TBL] [Abstract][Full Text] [Related]
18. Postmortem detection of 25I-NBOMe [2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine] in fluids and tissues determined by high performance liquid chromatography with tandem mass spectrometry from a traumatic death.
Poklis JL; Devers KG; Arbefeville EF; Pearson JM; Houston E; Poklis A
Forensic Sci Int; 2014 Jan; 234():e14-20. PubMed ID: 24215811
[TBL] [Abstract][Full Text] [Related]
19. Experimental Study on the Postmortem Redistribution of the Substituted Phenethylamine, 25B-NBOMe.
Shintani-Ishida K; Saka K; Nakamura M; Yoshida KI; Ikegaya H
J Forensic Sci; 2018 Mar; 63(2):588-591. PubMed ID: 28643397
[TBL] [Abstract][Full Text] [Related]
20. New psychoactive substances in Turkey: Narcotics cases assessed by the Council of Forensic Medicine between 2016 and 2017 in Ankara, Turkey.
Göl E; Çok I
Forensic Sci Int; 2019 Jan; 294():113-123. PubMed ID: 30502695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
